Akt in Prostate Cancer: Possible Role in Androgen-Independence

Author(s): Paramita M. Ghosh, Shazli Malik, Roble Bedolla, Jeffrey I. Kreisberg.

Journal Name: Current Drug Metabolism

Volume 4 , Issue 6 , 2003

Become EABM
Become Reviewer

Abstract:

Akt, a downstream effector of phosphatidylinositol 3-kinase (PI3K), has often been implicated in prostate cancer. Studies in prostate tumor cell lines revealed that Akt activation is probably important for the progression of prostate cancer to an androgen-independent state. Investigations of human prostate cancer tissues show that although there is neither Akt gene amplification nor enhanced protein expression in prostate cancer compared to normal tissue, poorly differentiated tumors exhibit increased expression of a phosphorylated (activated) form of Akt compared to normal tissue, prostatic intraepithelial neoplasia (PIN) or well-differentiated prostate cancer. Akt phosphorylation is accompanied by the inactivation of ERK, a member of the mitogen activated protein kinase (MAPK) family. In this article, we postulate that Akt promotes androgen-independent survival of prostate tumor cells by modulating the expression and activation of the androgen receptor (AR).

Keywords: akt, pi3k, androgen receptor, mapk, pten, prostate cancer

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 4
ISSUE: 6
Year: 2003
Page: [487 - 496]
Pages: 10
DOI: 10.2174/1389200033489226
Price: $58

Article Metrics

PDF: 4